Estrella Immunopharma Inc (ESLA)
NASDAQ
Fin d'année 30 Juin 2024 | 2021 | 2022 | 2024 |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -1.083 | -3.587 | -103.146 |
Return on Equity (%) | 49.304 | 61.067 | -725.037 |
Return on Invested Capital (%) | 49.454 | 89.856 | -878.11 |
Operating Margin (%) | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A |
Book Value Per Share | 7.552 | 3.035 | 0.115 |
Earnings Per Share | -0.042 | -0.427 | -0.196 |
Cash Per Share | 0.082 | 0.018 | 0.112 |
Working Capital Per Share | 0.093 | -0.438 | 0.115 |
Operating Profit Per Share | N/A | N/A | N/A |
EBIT Per Share | -0.042 | -0.393 | -0.196 |
EBITDA Per Share | -0.042 | -0.393 | -0.196 |
Free Cash Flow Per Share | -0.042 | -0.427 | -0.196 |
Fin d'année 30 Juin 2024 | 2021 | 2022 | 2024 |
---|---|---|---|
Current Ratio | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A |
Actions en circulation | 1,42M | 1,42M | N/A |
Fin d'année 30 Juin 2024 | Juin 2022 | Sept 2022 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Mar 2024 | Juin 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | ||||||
Actions en circulation | 1,42M | 1,42M | 1,42M | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 27,56M |
Ratio cours/bénéfice | -3,91 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 6,86 |
Ratio prix/valeur comptable | 6,69 |
Rendement de dividende | - |
Actions en circulation | 36,19M |
Volume moyen (1 semaine) | 17,93k |
Volume moyen (1 mois) | 22,29k |
Variation sur 52 semaines | -38,69% |
Plus haut sur 52 semaines | 3,23 |
Plus bas sur 52 semaines | 0,63 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales